• FDA Hearing on Social Media
  At the landmark FDA hearing on social media, companies had an opportunity to share their perspective and recommendations with the FDA to help determine guidelines. In this post, we've summarized some key insights and opinions from the hearings.
• I Have Seen the Future and It's Your Phone

Earlier this month, Wendy White presented "Building Relationships with Empowered Patients" at the NORD Corporate Council Meeting in Washington, DC. Wendy discussed how social media can effectively reach and connect patients with rare disorders, and also talked about how Siren is partnering with NORD for Rare Disease Day 2010. Read more information here.

Siren's work with Baxter on Aralast was recently featured on the Dose of Digital blog as a great example of meaningful marketing that provides value. Aralast is a treatment for alpha-1 antitrypsin (AAT) deficiency, which affects about 100,000 people in the U.S., 95% of who are currently undiagnosed. The marketing of Aralast, which comes in the form of free test kits, was recognized as an effective and meaningful way to drive awareness while improving people's lives.